BACKGROUND: Cigarette smoking causes accelerated facial wrinkling and predisposes to chronic obstructive pulmonary disease (COPD). However, it has long been recognised that there is a subgroup of susceptible smokers who are at increased risk of developing airflow obstruction. We have tested the hypothesis that there is a common susceptibility for the development of COPD and facial wrinkling in cigarette smokers. METHODS: One hundred and forty nine current and ex-smokers were recruited from a family based study of COPD genetics, 68 (45.6%) of whom fulfilled the definition of COPD. 124 (83.2%) had no or minor facial wrinkling (Daniell <IV) and 25 (16.8%) were wrinkled (Daniell score >/=IV). Generalised estimating equations were used to adjust for familial correlations between related individuals and the potential confounding effects of age and pack years smoked. RESULTS: Forced expiratory volume in 1 second (FEV(1)) was significantly lower in those with wrinkles than in those without (mean difference in FEV(1) % predicted -13.7%, 95% CI -27.5 to 0.0, p = 0.05) and facial wrinkling was associated with a substantially increased risk of COPD (adjusted OR 5.0, 95% CI 1.3 to 18.5, p<0.02). The Daniell score correlated with the extent of emphysema on the CT scan (p<0.05) and facial wrinkling was also associated with a greater risk of more extensive emphysema (adjusted OR 3.0, 95% CI 1.0 to 9.3, p = 0.05). CONCLUSION: Facial wrinkling is associated with COPD in smokers, and both disease processes may share a common susceptibility. Facial wrinkling in smokers may therefore be a biomarker of susceptibility to COPD.
BACKGROUND: Cigarette smoking causes accelerated facial wrinkling and predisposes to chronic obstructive pulmonary disease (COPD). However, it has long been recognised that there is a subgroup of susceptible smokers who are at increased risk of developing airflow obstruction. We have tested the hypothesis that there is a common susceptibility for the development of COPD and facial wrinkling in cigarette smokers. METHODS: One hundred and forty nine current and ex-smokers were recruited from a family based study of COPD genetics, 68 (45.6%) of whom fulfilled the definition of COPD. 124 (83.2%) had no or minor facial wrinkling (Daniell <IV) and 25 (16.8%) were wrinkled (Daniell score >/=IV). Generalised estimating equations were used to adjust for familial correlations between related individuals and the potential confounding effects of age and pack years smoked. RESULTS: Forced expiratory volume in 1 second (FEV(1)) was significantly lower in those with wrinkles than in those without (mean difference in FEV(1) % predicted -13.7%, 95% CI -27.5 to 0.0, p = 0.05) and facial wrinkling was associated with a substantially increased risk of COPD (adjusted OR 5.0, 95% CI 1.3 to 18.5, p<0.02). The Daniell score correlated with the extent of emphysema on the CT scan (p<0.05) and facial wrinkling was also associated with a greater risk of more extensive emphysema (adjusted OR 3.0, 95% CI 1.0 to 9.3, p = 0.05). CONCLUSION: Facial wrinkling is associated with COPD in smokers, and both disease processes may share a common susceptibility. Facial wrinkling in smokers may therefore be a biomarker of susceptibility to COPD.
Authors: B Lundbäck; A Lindberg; M Lindström; E Rönmark; A C Jonsson; E Jönsson; L G Larsson; S Andersson; T Sandström; K Larsson Journal: Respir Med Date: 2003-02 Impact factor: 3.415
Authors: S C McCloskey; B D Patel; S J Hinchliffe; E D Reid; N J Wareham; D A Lomas Journal: Am J Respir Crit Care Med Date: 2001-10-15 Impact factor: 21.405
Authors: Cornelis Kennedy; Maarten T Bastiaens; Chris D Bajdik; Rein Willemze; Rudi G J Westendorp; Jan N Bouwes Bavinck Journal: J Invest Dermatol Date: 2003-04 Impact factor: 8.551
Authors: E K Silverman; H A Chapman; J M Drazen; S T Weiss; B Rosner; E J Campbell; W J O'DONNELL; J J Reilly; L Ginns; S Mentzer; J Wain; F E Speizer Journal: Am J Respir Crit Care Med Date: 1998-06 Impact factor: 21.405
Authors: Ying Shi; Jiaofei Cao; Jane Gao; Liang Zheng; Andrew Goodwin; Chang Hyoek An; Avignat Patel; Janet S Lee; Steven R Duncan; Naftali Kaminski; Kusum V Pandit; Ivan O Rosas; Augustine M K Choi; Danielle Morse Journal: Am J Respir Crit Care Med Date: 2012-06-28 Impact factor: 21.405
Authors: David A McAllister; John D Maclay; Nicholas L Mills; Grant Mair; Joy Miller; David Anderson; David E Newby; John T Murchison; William Macnee Journal: Am J Respir Crit Care Med Date: 2007-09-20 Impact factor: 21.405
Authors: Sivasubramanium Bhavani; Chu-Lin Tsai; Sarah Perusich; Sean Hesselbacher; Harvey Coxson; Lavannya Pandit; David B Corry; Farrah Kheradmand Journal: Am J Respir Crit Care Med Date: 2015-11-15 Impact factor: 21.405
Authors: Michael H Cho; Dawn M Ciulla; Barbara J Klanderman; Craig P Hersh; Augusto A Litonjua; David Sparrow; Benjamin A Raby; Edwin K Silverman Journal: Am J Respir Cell Mol Biol Date: 2008-11-21 Impact factor: 6.914